Vanderbilt launches cancer decision support tool
Vanderbilt-Ingram Cancer Center (VICC) has launched the nation's first personalized cancer decision-support Web site that will collect and distribute information about the expanding list of genetic mutations that impact different cancers, as well as provide links to research documents on various treatment options based on specific mutations.
The online tool, My Cancer Genome, is linked to Vanderbilt University Medical Center's StarPanel electronic medical record (EMR) database, giving physicians the ability to cross-reference patients' medical histories, lab results, medications, and other medical information with online data that tracks the latest developments in personalized cancer medicine and clinical research.
- Primary Care Docs Average More Hospital Revenue Than Specialists
- How Chargemaster Data May Affect Hospital Revenue
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- House Lawmakers Grill CMS Over Health Exchange Navigators
- Insurer's App Aims to Lower Healthcare Costs, Securely
- Fortunately, Angelina Jolie Isn't On Medicare
- ED Physicians Key to Half of Hospital Admissions
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- Don't Let Nurses Sink Your Bottom Line
- Q&A: Catholic Health Initiatives' New Senior VP for Capital Finance